Facebook
Twitter
Telegram
Report an ErrorAtara Biotherapeutics Financial Statements 2011-2024 | ATRA
Annual Financial Statements Atara Biotherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
73.1 M | 519 M | 1.48 B | 1.45 B | 698 M | 1.58 B | 1.2 B | 363 M | 463 M | 121 M | - | - | - |
Shares |
106 M | 102 M | 93.7 M | 74 M | 51.3 M | 43.8 M | 29.9 M | 28.7 M | 25.6 M | 4.99 M | - | - | - |
Historical Prices |
0.69 | 5.09 | 15.8 | 19.6 | 16.5 | 34.7 | 18.1 | 14.2 | 26.4 | 26.8 | - | - | - |
Net Income |
-276 M | -228 M | -340 M | -307 M | -291 M | -231 M | -119 M | -79 M | -57.2 M | -28 M | -8.77 M | - | - |
Revenue |
8.57 M | 63.6 M | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-276 M | -281 M | -340 M | -309 M | -296 M | -237 M | -122 M | -81.2 M | -58.4 M | -28.2 M | -8.62 M | - | - |
Interest Expense |
5.28 M | 373 K | 367 K | 2.45 M | 4.72 M | 6.37 M | 2.03 M | 2.2 M | 1.22 M | 125 K | 12 K | - | - |
EBITDA |
-271 M | -275 M | -331 M | -301 M | -289 M | -233 M | -121 M | -80.9 M | -58.4 M | -28.2 M | -8.61 M | - | - |
Operating Expenses |
- | - | 361 M | 309 M | 296 M | 237 M | 122 M | 81.2 M | 58.4 M | 28.2 M | - | - | - |
General and Administrative Expenses |
50.9 M | 71.6 M | 78.8 M | 64.4 M | 79.6 M | 69.7 M | 40.3 M | 24.7 M | 16.8 M | 12.7 M | 3.76 M | - | - |
All numbers in USD currency
Quarterly Income Statement Atara Biotherapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
141 M | 106 M | 106 M | 105 M | 104 M | 95.9 M | 102 M | 102 M | 101 M | 91.7 M | 93.6 M | 92.2 M | 91.5 M | 83.4 M | 81.2 M | 68 M | 61.2 M | 56.8 M | 54.9 M | 46.4 M | 46.1 M | 46 M | 45.4 M | 44.4 M | 39.6 M | 30.7 M | 30.5 M | 29.2 M | 29.1 M | 28.9 M | 28.8 M | 28.7 M | 28.5 M | 28.5 M | 27.7 M | 24.2 M | 21.9 M | 19.7 M | 1.41 B | 1.34 M | 1.26 M | 12 M | 978 K | - | - | 733 K | - | - | - | - | - | - | - |
Net Income |
-31.8 M | - | -69.8 M | -71.1 M | -74.8 M | - | -84.1 M | 18.5 M | -88.1 M | - | -84.7 M | -83.8 M | -78.3 M | - | -74.3 M | -77.5 M | -73.5 M | - | -71.9 M | -74.3 M | -66.3 M | - | -58.4 M | -50.9 M | -41.4 M | - | -31.1 M | -27.4 M | -25.7 M | - | -25.4 M | -18.9 M | -16.6 M | - | -11.9 M | -14.9 M | -9.16 M | - | -5.92 M | -4.51 M | -7.05 M | - | -2.54 M | - | - | -4.11 M | - | - | - | - | - | - | - |
Revenue |
27.4 M | - | 2.14 M | 957 K | 1.23 M | - | 4.46 M | 51.6 M | 7.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-31.2 M | - | -69.6 M | -71.4 M | -75 M | - | -84.6 M | -32.1 M | -88.2 M | - | -84.8 M | -84 M | -78.2 M | - | -74.7 M | -78 M | -74.7 M | - | -72.6 M | -75.5 M | -67.9 M | - | -60.2 M | -52.6 M | -42.5 M | - | -31.7 M | -27.9 M | -26.2 M | - | -25.9 M | -19.5 M | -17.1 M | - | -12.3 M | -15.1 M | -9.31 M | - | -5.95 M | -4.53 M | -7.08 M | - | -2.55 M | - | - | -4.09 M | - | - | - | - | - | - | - |
Interest Expense |
1.15 M | - | 1.4 M | 1.38 M | 1.34 M | - | 123 K | 129 K | 4 K | - | 148 K | 225 K | -90 K | - | 364 K | 497 K | 1.19 M | - | 661 K | 1.21 M | 1.63 M | - | 1.86 M | 1.74 M | 1.01 M | - | 564 K | 481 K | 509 K | - | 576 K | 605 K | 503 K | - | 380 K | 163 K | 153 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-29.9 M | - | -68.7 M | -70.5 M | -73.8 M | - | -83.5 M | -30.7 M | -86.6 M | - | -82.5 M | -81.7 M | -76 M | - | -72.5 M | -75.9 M | -72.7 M | - | -70.8 M | -73.7 M | -66.2 M | - | -59 M | -51.9 M | -42.1 M | - | -31.4 M | -27.7 M | -26 M | - | -25.8 M | -19.4 M | -17 M | - | -12.2 M | -15.1 M | -9.3 M | - | -5.94 M | -4.53 M | -7.08 M | - | -2.55 M | - | - | -4.09 M | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | 72.4 M | 76.2 M | - | 89.1 M | 83.7 M | 95.5 M | - | 90.2 M | 87.9 M | 81.8 M | - | 74.7 M | 78 M | 74.7 M | - | 72.6 M | 75.5 M | 67.9 M | - | 60.2 M | 52.6 M | 42.5 M | - | 31.7 M | 27.9 M | 26.2 M | - | 25.9 M | 19.5 M | 17.1 M | - | 12.3 M | 15.1 M | 9.31 M | - | 5.95 M | 4.53 M | 7.08 M | - | 2.55 M | - | - | 4.09 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
11.1 M | - | 12.2 M | 13.3 M | 13.9 M | - | 18.9 M | 18.8 M | 20.6 M | - | 19.8 M | 19.4 M | 17.7 M | - | 14.8 M | 16.4 M | 17 M | - | 19 M | 23.3 M | 19.2 M | - | 16.9 M | 19.2 M | 14 M | - | 11.1 M | 9.61 M | 8.62 M | - | 7.14 M | 6.49 M | 5.81 M | - | 4.15 M | 3.6 M | 3.54 M | - | 1.71 M | 1.36 M | 4.1 M | - | 868 K | - | - | 834 K | - | - | - | - | - | - | - |
All numbers in USD currency